LataMed AI is trading 6.23% up now at $0.51, continuing investor reaction to its mobile healthcare application entering final testing.
- The August 19 announcement said the app entered final testing ahead of planned Apple App Store and Google Play submissions.
- Management expects submissions in the coming weeks, subject to platform review and technical requirements.
- No separate August 24 company announcement was identified; broader markets are mixed, limiting evidence of a market-wide catalyst.